← All companies
Adaptive Biotechnologies Corp
ADPT - CIK 0001478320
Market cap$2.73 B
Rank#1887
SEC filings764
Adaptive Biotechnologies Corp trades as ADPT and has a market capitalization of $2.73 B, making it the #1887 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $276.98M, up 54.8% from the prior year and net income of -$59.50M. This page tracks Adaptive Biotechnologies Corp through 764 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$276.98MFY 2025
Net income (latest FY)-$59.50MFY 2025
Operating cash flow (latest FY)-$45.99MFY 2025
Total assets (latest FY)$512.74MFY 2025
Net margin-21.5%latest FY
Financial performance
Over the last 8 fiscal years Adaptive Biotechnologies Corp's revenue grew from $38.45M to $276.98M, a compound annual growth rate of 28.0%. Net profit margin expanded from -111.4% to -21.5% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $2.73 B
- Share price (derived)market cap / shares outstanding
- $17.07
- EPS (diluted)FY 2025
- $-0.39
- Shares outstandingas of 2026-04-30
- 0.16B
- Total equityas of 2026-03-31
- $216.34M
- Return on equity
- -27.5%
- Long-term debtas of 2026-03-31
- $124.75M
- Cash & equivalentsas of 2026-03-31
- $77.58M
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-05 |
| Major company event | 8-K | 2026-05-05 |
| Insider trade | 4 | 2026-04-29 |
| Insider trade | 4 | 2026-04-24 |
| Annual report to shareholders | ARS | 2026-04-24 |
Similar companies
The largest companies sharing Adaptive Biotechnologies Corp's SEC industry classification (biological products, (no diagnostic substances)).
Frequently asked questions
What is Adaptive Biotechnologies Corp's market cap?
Adaptive Biotechnologies Corp (ADPT) has a market capitalization of $2.73 B as of 2026-06-11, ranking #1887 among US-listed companies.
How much revenue does Adaptive Biotechnologies Corp make?
Adaptive Biotechnologies Corp reported revenue of $276.98M for fiscal year 2025, an increase of 54.8% year over year.
Is Adaptive Biotechnologies Corp profitable?
In its latest fiscal year Adaptive Biotechnologies Corp reported a net loss of $59.50M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.